 Oncolytics Biotech Inc. NASDAQ: ONCY TSX: ONC, currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that Matt Coffey, President CEO of Oncolytics Biotech, will present during the RBC Global Healthcare Conference at 1:55 pm Eastern Time on Wednesday, May 20, 2020. The conference is being held on May 19 20 in a virtual format. 